Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen A Harrison

Showing results (111-120 of 318) with videos related to

Pageof 32
Sort By:
Journal of Clinical Gastroenterology|May 19, 2009
A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: A randomized placebo-controlled trialAustin Nelson, Dawn M Torres, Ana E Morgan, et al.
World Journal of Hepatology|October 15, 2015
Pathogenesis of hepatocarcinogenesis in non-cirrhotic nonalcoholic fatty liver disease: Potential mechanistic pathwaysRyan B Perumpail, Andy Liu, Robert J Wong, et al.
Postgraduate Medicine|July 30, 2025
Plain language summary about GLP-1 treatments in people with metabolic dysfunction-associated steatotic liver diseaseLayla A Abushamat, Pir Ahmad Shah, Robert H Eckel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2021
Hepatic Fat Reduction Due to Resmetirom in Patients With Nonalcoholic Steatohepatitis Is Associated With Improvement of Quality of LifeZobair M Younossi, Maria Stepanova, Rebecca A Taub, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 17, 2024
The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated SteatohepatitisLayla A Abushamat, Pir Ahmad Shah, Robert H Eckel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 28, 2010
Manifestations of chronic hepatitis C virus infection beyond the liverIra M Jacobson, Patrice Cacoub, Luigino Dal Maso, et al.
Military Medicine|May 5, 2015
Syphilitic hepatitis uncommon presentation of an old scourgeChristopher J Mulder, Ryan S Cho, Stephen A Harrison, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 1, 2024
Degree of Discordance Between FIB-4 and Transient Elastography: An Application of Current Guidelines on General Population CohortMadeleine Chang, Devon Chang, Sudha Kodali, et al.
The American Journal of Gastroenterology|December 23, 2003
Cognitive lifetime drinking history in nonalcoholic fatty liver disease: some cases may be alcohol relatedPaul H Hayashi, Stephen A Harrison, Sigurd Torgerson, et al.
The American Journal of Gastroenterology|May 10, 2003
Orlistat in the treatment of NASH: a case seriesStephen A Harrison, Sanjay Ramrakhiani, Elizabeth M Brunt, et al.
Pageof 32

Showing results (111-120 of 318) with videos related to

Sort By:
Pageof 32
Journal of Clinical Gastroenterology|May 19, 2009
A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: A randomized placebo-controlled trialAustin Nelson, Dawn M Torres, Ana E Morgan, et al.
World Journal of Hepatology|October 15, 2015
Pathogenesis of hepatocarcinogenesis in non-cirrhotic nonalcoholic fatty liver disease: Potential mechanistic pathwaysRyan B Perumpail, Andy Liu, Robert J Wong, et al.
Postgraduate Medicine|July 30, 2025
Plain language summary about GLP-1 treatments in people with metabolic dysfunction-associated steatotic liver diseaseLayla A Abushamat, Pir Ahmad Shah, Robert H Eckel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2021
Hepatic Fat Reduction Due to Resmetirom in Patients With Nonalcoholic Steatohepatitis Is Associated With Improvement of Quality of LifeZobair M Younossi, Maria Stepanova, Rebecca A Taub, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 17, 2024
The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated SteatohepatitisLayla A Abushamat, Pir Ahmad Shah, Robert H Eckel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 28, 2010
Manifestations of chronic hepatitis C virus infection beyond the liverIra M Jacobson, Patrice Cacoub, Luigino Dal Maso, et al.
Military Medicine|May 5, 2015
Syphilitic hepatitis uncommon presentation of an old scourgeChristopher J Mulder, Ryan S Cho, Stephen A Harrison, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 1, 2024
Degree of Discordance Between FIB-4 and Transient Elastography: An Application of Current Guidelines on General Population CohortMadeleine Chang, Devon Chang, Sudha Kodali, et al.
The American Journal of Gastroenterology|December 23, 2003
Cognitive lifetime drinking history in nonalcoholic fatty liver disease: some cases may be alcohol relatedPaul H Hayashi, Stephen A Harrison, Sigurd Torgerson, et al.
The American Journal of Gastroenterology|May 10, 2003
Orlistat in the treatment of NASH: a case seriesStephen A Harrison, Sanjay Ramrakhiani, Elizabeth M Brunt, et al.
Pageof 32